By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mast Therapeutics 

12390 El Camino Real, Suite 150

San Diego  California  92130  U.S.A.
Phone: 858-552-0866 Fax: 858-552-0876


Company News
Mast Therapeutics (MSTX) To Present At The Piper Jaffray 27th Annual Healthcare Conference 11/24/2015 7:37:28 AM
Mast Therapeutics (MSTX) Release: Vepoloxamer Data Selected For Presentation At 57th Annual American Society of Hematology Meeting 11/16/2015 10:24:43 AM
Mast Therapeutics (MSTX) Reports Third Quarter 2015 Financial Results 11/12/2015 4:38:57 PM
Mast Therapeutics (MSTX) Release: Vepoloxamer Nonclinical Study Results In Advanced Heart Failure To Be Presented At 2015 American Heart Association Scientific Sessions 11/9/2015 10:59:14 AM
Mast Therapeutics (MSTX) Announces Appointment Of Peter Greenleaf To Board of Directors 11/9/2015 10:05:38 AM
Mast Therapeutics (MSTX) Announces Appointment Of Matthew Pauls To Board Of Directors 11/2/2015 6:36:26 AM
Mast Therapeutics (MSTX) To Host Third Quarter 2015 Financial Results And Corporate Update Conference Call 10/29/2015 8:10:42 AM
Mast Therapeutics (MSTX) Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure 10/26/2015 8:26:37 AM
BASF To Develop A High Purity Poloxamer For Mast Therapeutics (MSTX) 10/13/2015 10:40:38 AM
Mast Therapeutics (MSTX) Announces Amendment To Loan And Security Agreement With Hercules Technology Growth Capital 9/30/2015 6:38:47 AM